INS and Abdominal obesity: Central obesity, notably excessive visceral fat, is associated with multiple metabolic alterations affecting blood cholesterol, glucose, and insulin levels, that can lead to cardio- and cerebrovascular disease and Type 2 diabetes (Dommermuth and Ewing, 2018; Whitmer et al., 2007).